BMYNYSELive delayed
$62.56
+0.47+0.76%
SourceCNBCAs ofJul 27, 2026, 8:10 PM
Delayed market data from CNBC. Not investment advice.
Bristol-Myers Squibb is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for BMY · Finnhub.
- Market cap
- $128.59B
- P/E (TTM)
- 18.23
- EPS (TTM)
- $3.3635
- Div. yield
- 4.06%
- 52-week range
- $42.52 – $62.89
- Volume
- —
- Avg volume
- 10.55M
Price history
OHLC candles for BMY · 3mo · 1d · Yahoo Finance · delayed · EMA / RSI
+7.38%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings? Zacks Investment ResearchBroad market headline — check whether risk appetite shifts.
Watch: BMY · .SPX · .FTSE · .N225
DirectHigh impactGoogle News
Bristol Myers Squibb (NYSE:BMY) Reaches New 52-Week High - Should You Buy?DirectHigh impactGoogle News
Wall Street's Insights Into Key Metrics Ahead of Bristol Myers (BMY) Q2 EarningsDirectHigh impactGoogle News
SummitTX Capital L.P. Buys 89,097 Shares of Bristol Myers Squibb Company $BMYDirectHigh impactGoogle News
Bristol Myers Squibb Company $BMY Shares Purchased by OMERS ADMINISTRATION CorpDirectHigh impactGoogle News
Orbimed Advisors LLC Acquires 150,000 Shares of Bristol Myers Squibb Company $BMYDirectHigh impactGoogle News
Lombard Odier Asset Management Switzerland SA Buys 18,900 Shares of Bristol Myers Squibb Company $BMYDirectHigh impactGoogle News
Renaissance Technologies LLC Lowers Stock Position in Bristol Myers Squibb Company $BMY